BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers
Journal of Clinical Oncology · 10.02.2023 · 41 (5) · 991-999
DOI: 10.1200/jco.22.00833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.02.2023. Verfasst von Jie Sun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Familial & Hereditary Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University C…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
PURPOSE The absolute cumulative risk of contralateral breast cancer (CBC) for patients with BRCA1/ 2 variants is unknown. The purpose of this study was to develop a CBC risk prediction model for assessing CBC risk for BRCA1/ 2 carriers. METHODS The primary cohort of 491 patients with BRCA1/ 2 variants was derived from a large series of unselected patients with breast cancer. A nomogram was established on the basis of the results of a multivariate Cox regression analysis from this cohort. This model, named BRCA-CRisk, was further validated by an independent cohort of 205 patients with BRCA1/ 2 variants. Discrimination and calibration of the model were assessed. RESULTS In the primary cohort of 491 patients, 66 developed contralateral breast cancer after a median follow-up of 7.0 years. Four variables were significantly associated with risk of CBC and were incorporated in the establishment of the BRCA-CRisk prediction model: younger age at first breast cancer (with continuous variable, P = .002), positive first-degree family history of breast and/or ovarian cancer (hazard ratio [HR], 1.89; 95% CI, 1.16 to 3.08; P = .011), variant located near the 3′ region of BRCA (HR, 2.01; 95% CI, 1.23 to 3.30; P = .006), and endocrine therapy (HR, 0.54; 95% CI, 0.33 to 0.88; P = .013). The area under the time-dependent curves for the 5- and 10-year cumulative risks of CBC were 0.775 and 0.702, respectively. The model was well validated in the independent cohort of 205 BRCA1/ 2 carriers, with area under the curves of 0.750 and 0.691 for 5 and 10 years, respectively. CONCLUSION BRCA-CRisk model provides a useful tool for assessing the absolute cumulative risk of CBC for BRCA1/ 2 carriers and may help carriers and clinicians optimally select risk-reducing strategies on the basis of individual CBC risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Familial & Hereditary Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, P. R. China.
- Department of Breast Surgery, Peking University International Hospital, Beijing, P. R. China.
- Department of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, P…
- Zhejiang Chinese Medical University, Hangzhou, P. R. China.
ORCID-Profile: Jie Sun, Futao Chu, Jiani Pan, Jiuan Chen, Ye Xu, Xiaojia Wang, Wenming Cao, Yuntao Xie
Zitieren
APA
Sun, J., Chu, F., Pan, J., Zhang, Y., Yao, L., Chen, J., Hu, L., Zhang, J., Xu, Y., Wang, X., Cao, W., & Xie, Y. (2023). BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers. Journal of Clinical Oncology, 41(5), 991-999. https://doi.org/10.1200/jco.22.00833
Vancouver
Sun J, Chu F, Pan J, Zhang Y, Yao L, Chen J, et al. BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers. Journal of Clinical Oncology. 2023;41(5):991-999. doi:10.1200/jco.22.00833
BibTeX
@article{Sun2023,
author = {Sun, Jie and Chu, Futao and Pan, Jiani and Zhang, Yaxin and Yao, Lu and Chen, Jiuan and Hu, Li and Zhang, Juan and Xu, Ye and Wang, Xiaojia and Cao, Wenming and Xie, Yuntao},
title = {BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {5},
pages = {991--999},
doi = {10.1200/jco.22.00833}
}
EUVIMED